Kjeld Hermansen Selected Research

Whey Proteins

1/2022	The Effects of 12-Weeks Whey Protein Supplements on Markers of Bone Turnover in Adults With Abdominal Obesity - A Post Hoc Analysis.
1/2021	Effects of whey protein and dietary fiber intake on insulin sensitivity, body composition, energy expenditure, blood pressure, and appetite in subjects with abdominal obesity.
1/2021	Effects of a whey protein pre-meal on bone turnover in participants with and without type 2 diabetes-A post hoc analysis of a randomised, controlled, crossover trial.
9/2019	Whey Protein Combined with Low Dietary Fiber Improves Lipid Profile in Subjects with Abdominal Obesity: A Randomized, Controlled Trial.
3/2019	A pre-meal of whey proteins induces differential effects on glucose and lipid metabolism in subjects with the metabolic syndrome: a randomised cross-over trial.
1/2019	The Combination of Whey Protein and Dietary Fiber Does Not Alter Low-Grade Inflammation or Adipose Tissue Gene Expression in Adults with Abdominal Obesity.
1/2018	Pre-Meal Effect of Whey Proteins on Metabolic Parameters in Subjects with and without Type 2 Diabetes: A Randomized, Crossover Trial.
8/2016	Whey and Casein Proteins and Medium-Chain Saturated Fatty Acids from Milk Do Not Increase Low-Grade Inflammation in Abdominally Obese Adults.
4/2015	Dairy proteins, dairy lipids, and postprandial lipemia in persons with abdominal obesity (DairyHealth): a 12-wk, randomized, parallel-controlled, double-blinded, diet intervention study.
5/2014	Whey protein delays gastric emptying and suppresses plasma fatty acids and their metabolites compared to casein, gluten, and fish protein.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kjeld Hermansen Research Topics

Disease

36	Type 2 Diabetes Mellitus (MODY) 01/2021 - 05/2002
21	Insulin Resistance 01/2021 - 12/2004
21	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021 - 12/2004
8	Body Weight (Weight, Body) 01/2022 - 09/2005
8	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2003
8	Hyperlipidemias (Hyperlipidemia) 01/2021 - 07/2002
7	Inflammation (Inflammations) 11/2019 - 01/2011
7	Hyperglycemia 01/2017 - 07/2002
7	Hypoglycemia (Reactive Hypoglycemia) 01/2016 - 06/2006
6	Weight Gain 09/2019 - 06/2006
5	Abdominal Obesity 01/2022 - 04/2015
5	Overweight 12/2017 - 03/2003
4	Hypertension (High Blood Pressure) 01/2014 - 08/2004
3	Dyslipidemias (Dyslipidemia) 01/2018 - 09/2005
3	Weight Loss (Weight Reduction) 03/2017 - 04/2008
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 11/2012 - 07/2002
3	Coronary Disease (Coronary Heart Disease) 04/2011 - 01/2003
2	Diabetes Mellitus 01/2020 - 01/2016
2	Bone Resorption 01/2020 - 01/2017
2	Fatty Liver 09/2019 - 10/2018
2	Obesity 02/2018 - 01/2016
2	Neoplasms (Cancer) 09/2012 - 10/2005
2	Diabetes Complications 04/2008 - 05/2002
1	Hyperinsulinism (Hyperinsulinemia) 12/2017
1	Insulinoma 10/2015

Drug/Important Bio-Agent (IBA)

27	Insulin (Novolin)FDA Link 01/2020 - 05/2002
20	Glucose (Dextrose)FDA LinkGeneric 08/2020 - 05/2002
12	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2005
12	Whey ProteinsIBA 01/2022 - 07/2009
12	LipidsIBA 08/2020 - 01/2003
9	Triglycerides (Triacylglycerol)IBA 01/2022 - 03/2003
9	Fatty Acids (Saturated Fatty Acids)IBA 12/2017 - 03/2003
8	CarbohydratesIBA 03/2018 - 03/2003
6	Caseins (Casein)FDA Link 02/2019 - 07/2009
5	CholesterolIBA 01/2022 - 01/2006
5	Coffee FDA Link 09/2019 - 09/2012
5	Glucagon (Glukagon)FDA Link 01/2017 - 10/2005
5	Hypoglycemic Agents (Hypoglycemics)IBA 01/2016 - 03/2006
4	IncretinsIBA 01/2021 - 03/2003
4	Biomarkers (Surrogate Marker)IBA 02/2018 - 01/2014
4	Insulin Detemir (Levemir)FDA Link 09/2011 - 06/2006
4	steviosideIBA 03/2006 - 01/2004
3	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2021 - 03/2003
3	Dietary Fiber FDA Link 01/2021 - 01/2019
3	Rapeseed OilIBA 11/2019 - 06/2014
3	Glutens (Glutelin)IBA 02/2019 - 07/2009
3	oxidized low density lipoproteinIBA 03/2018 - 01/2003
3	Insulin Aspart (NovoLog)FDA Link 01/2016 - 09/2011
3	Dietary Fats (Dietary Fat)IBA 01/2011 - 10/2005
3	Monounsaturated Fatty AcidsIBA 01/2011 - 04/2008
3	Isophane Insulin (NPH Insulin)FDA Link 06/2006 - 05/2002
2	HDL CholesterolIBA 01/2022 - 03/2003
2	Collagen Type I (Type I Collagen)IBA 01/2021 - 01/2020
2	ProcollagenIBA 01/2021 - 01/2020
2	maltodextrinIBA 01/2021 - 01/2019
2	Blood Glucose (Blood Sugar)IBA 01/2020 - 04/2008
2	arabinoxylanIBA 03/2018 - 01/2016
2	Resistant StarchIBA 03/2018 - 01/2016
2	AdiponectinIBA 12/2017 - 08/2016
2	ChylomicronsIBA 04/2015 - 07/2009
2	Dietary ProteinsIBA 01/2013 - 10/2011
2	Pharmaceutical PreparationsIBA 01/2012 - 12/2006
2	glimepiride (Amarel)FDA LinkGeneric 07/2010 - 01/2009
2	Metformin (Glucophage)FDA LinkGeneric 07/2010 - 01/2009
2	Liraglutide FDA Link 07/2010 - 01/2009
2	Enalapril FDA LinkGeneric 01/2007 - 08/2004
2	Indapamide FDA LinkGeneric 01/2007 - 08/2004
2	FatsIBA 02/2006 - 03/2003
2	OligonucleotidesIBA 01/2006 - 12/2005
2	rebaudioside AIBA 01/2005 - 10/2004
2	Lipoproteins (Lipoprotein)IBA 01/2004 - 03/2003
2	Biphasic InsulinsIBA 07/2002 - 05/2002
2	insulin aspart protamine drug combination 30:70 insulin aspartIBA 07/2002 - 05/2002
2	biphasic human insulin 30IBA 07/2002 - 05/2002
1	HDL LipoproteinsIBA 01/2022
1	EnzymesIBA 01/2021
1	Hormones (Hormone)IBA 01/2021
1	Peptide YYIBA 01/2021
1	Parathyroid Hormone (Parathormone)IBA 01/2021
1	OsteocalcinIBA 01/2021
1	3-Hydroxybutyric Acid (beta-Hydroxybutyric Acid)IBA 08/2019
1	Apolipoprotein B-48IBA 03/2019
1	GTP-Binding Proteins (G-Protein)IBA 02/2019
1	FructoseIBA 10/2018
1	Butyrates (Butyrate)IBA 10/2018
1	SugarsIBA 10/2018
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2018
1	MicroRNAs (MicroRNA)IBA 02/2018
1	ATP Binding Cassette Transporter 1IBA 02/2018
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 02/2018
1	Gastrointestinal Hormones (Hormones, Gastrointestinal)IBA 01/2017
1	cafestolIBA 01/2017
1	Volatile Fatty AcidsIBA 01/2016
1	Insulin AntibodiesIBA 01/2016
1	Proline (L-Proline)FDA Link 01/2016

Therapy/Procedure

10	Glycemic Control 12/2017 - 05/2002
8	Therapeutics 11/2012 - 01/2004
2	Drug Therapy (Chemotherapy) 01/2007 - 06/2006
1	Reducing Diet 01/2020
1	High-Protein Diet 01/2020